APH — Alliance Pharma Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual income statement for Alliance Pharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	130	163	167	181	179
Cost of Revenue
Gross Profit	82.8	109	102	105	109
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	113	142	185	219	187
Operating Profit	16.3	21.6	-17.7	-38.4	-8.1
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	13	18.2	-23.1	-48.8	-14.5
Provision for Income Taxes
Net Income After Taxes	8.03	7.32	-21.2	-33.1	-10.7
Net Income Before Extraordinary Items
Net Income	8.03	7.32	-21.2	-33.1	-10.7
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	8.03	7.32	-21.2	-33.1	-10.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.043	0.025	0.063	0.116	0.075
Dividends per Share